Literature DB >> 6859869

Transport of methotrexate in Chinese hamster ovary cells: a mutant defective in methotrexate uptake and cell binding.

W F Flintoff, C R Nagainis.   

Abstract

The uptake of several folate compounds has been investigated in wild-type and one class of methotrexate-resistant Chinese hamster ovary cells. The wild-type cells can take up methotrexate, folic acid, and 5-methyl tetrahydrofolate. The uptake of methotrexate is characterized by a KT of 1.9 +/- 0.2 microM and a Vmax of 1 +/- 0.8 pmol/min/mg protein, is competitively inhibited by folic acid and 5-methyl tetrahydrofolate, and is sensitive to p-hydroxymercuriphenyl sulfonic acid. The resistant cells are unable to take up methotrexate, folic acid, and 5-methyl tetrahydrofolate. In addition, the resistant cells are unable to bind methotrexate specifically, whereas the wild-type cells bind the drug with an apparent KD of 2 +/- 0.4 microM and a Vmax of 1.3 +/- 0.3 pmol/mg protein. These data indicate that the resistant cells are resistant because of an inability to take up the drug resulting from a defective membrane-binding component. The data also suggest that both methotrexate and folic acid are transported by the same system in Chinese hamster ovary cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6859869     DOI: 10.1016/0003-9861(83)90607-0

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  16 in total

1.  Cytoplasmic domains of the reduced folate carrier are essential for trafficking, but not function.

Authors:  Heather Sadlish; Frederick M R Williams; Wayne F Flintoff
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

2.  Fluorine-Substituted Pyrrolo[2,3- d]Pyrimidine Analogues with Tumor Targeting via Cellular Uptake by Folate Receptor α and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide Biosynthesis.

Authors:  Manasa Ravindra; Mike R Wilson; Nian Tong; Carrie O'Connor; Mohammad Karim; Lisa Polin; Adrianne Wallace-Povirk; Kathryn White; Juiwanna Kushner; Zhanjun Hou; Larry H Matherly; Aleem Gangjee
Journal:  J Med Chem       Date:  2018-04-27       Impact factor: 7.446

3.  Complementation of a methotrexate uptake defect in Chinese hamster ovary cells by DNA-mediated gene transfer.

Authors:  T M Underhill; W F Flintoff
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

4.  Identification of methotrexate transport deficiency in mammalian cells using fluoresceinated methotrexate and flow cytometry.

Authors:  Y G Assaraf; R T Schimke
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

5.  Design, synthesis and biological evaluation of novel pyrrolo[2,3-d]pyrimidine as tumor-targeting agents with selectivity for tumor uptake by high affinity folate receptors over the reduced folate carrier.

Authors:  Lalit K Golani; Farhana Islam; Carrie O'Connor; Aamod S Dekhne; Zhanjun Hou; Larry H Matherly; Aleem Gangjee
Journal:  Bioorg Med Chem       Date:  2020-05-06       Impact factor: 3.641

6.  Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate.

Authors:  M E Fling; J Kopf; A Tamarkin; J A Gorman; H A Smith; Y Koltin
Journal:  Mol Gen Genet       Date:  1991-06

7.  Mutations in the reduced-folate carrier affect protein localization and stability.

Authors:  H Sadlish; R C Murray; F M Williams; W F Flintoff
Journal:  Biochem J       Date:  2000-03-01       Impact factor: 3.857

8.  Prodrug forms of N-[(4-deoxy-4-amino-10-methyl)pteroyl]glutamate-gamma-[psiP(O)(OH)]-glutarate, a potent inhibitor of folylpoly-gamma-glutamate synthetase: synthesis and hydrolytic stability.

Authors:  Yan Feng; James K Coward
Journal:  J Med Chem       Date:  2006-01-26       Impact factor: 7.446

9.  Stable transfectants of human MCF-7 breast cancer cells with increased levels of the human folate receptor exhibit an increased sensitivity to antifolates.

Authors:  K N Chung; Y Saikawa; T H Paik; K H Dixon; T Mulligan; K H Cowan; P C Elwood
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

10.  The immunogenic properties of drug-resistant murine tumor cells do not correlate with expression of the MDR phenotype.

Authors:  J J Killion; R Radinsky; Z Dong; R Fishbeck; P Whitworth; I J Fidler
Journal:  Cancer Immunol Immunother       Date:  1993-06       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.